Ultima Genomics announces that it will provide three trillion DNA sequencing reads free of charge to researchers across the ...

Single-Molecule Footprinting reveals that RNA polymerase II (Pol II) occupancy is infrequent at mouse promoters. This results ...

How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...

The authors have generated important resources such as a reference dataset of early primate development by utilizing single-cell transcriptomic technology together with induced pluripotent stem cells ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

Illumina (NASDAQ:ILMN) on Monday lowered its adjusted profit outlook and cut spending costs for 2025 as the company grapples with a Chinese ban on its gene sequencers. Illumina now expects fiscal ...

Illumina (ILMN) said it is instituting an incremental approximately $100M cost reduction program for fiscal 2025. The company added, “These savings would mitigate the impact of a range of ...

China accounts for about 7% of Illumina’s sales. Gene sequencers help determine the sequence of DNA or RNA, allowing scientists to study genetic variations associated with diseases and diagnose ...

Illumina Inc's NovaSeq X Plus gene sequencing system is shown in this undated handout photo obtained by Reuters ...

Illumina ILMN has outperformed the market over the past 20 years by 8.97% on an annualized basis producing an average annual return of 17.25%. Currently, Illumina has a market capitalization of $ ...